This important study demonstrates the potential of synthetic gene circuits to detect and target aberrant RAS activity in cancer cell lines. The circuit design is novel and the evidence supporting the ...

Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

1Department of Obstetrics and Gynecology, Peking University Third Hospital, China 2Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing, China. 3Biobank, Peking ...

Objective Patients with myasthenia gravis without acetylcholine receptor (AChR) or muscle-specific kinase (MuSK) antibodies detected by radioimmunoprecipitation assays (RIAs) are classified as ...

There's no single answer that applies to all people. Prognosis depends in part on the type of lung cancer, whether small cell lung cancer or non-small cell lung cancer (which also has many subtypes).

Non-small cell cancer (NSCLC) tumor markers are signs of specific types of tumors. Doctors look for these markers to aid in the diagnosis and treatment of lung cancer. Doctors use several tests to ...

These "kicked" cells can then be targeted ("killed") by immunotherapies to fully clear the insidious virus from the body. By pursuing this "kick and kill" strategy with EBC-46, researchers think ...

Study unveils key immune cells found to boost cancer treatment success in acute myeloid leukemia New computational tool aims to identify immune responses to cellular therapy in AML treatments Date ...

Researcher Paul Hergenrother and colleagues improved upon their earlier research that involved development of a small molecule called ErSo which had the potential to kill ER+ breast cancer cells ...

After treating a tumor ... process of cell death. The authors note that "when we looked at potential therapeutic strategies, we observed senolytic activity, i.e. the ability to kill senescent ...

They examined the response of monolayers of rodent brain cancer cells to various therapy combinations ... of this set-up was measured as 8.9. Using a clonogenic assay to measure cell survival, the ...

In a significant step forward for India’s cancer treatment, Immuneel Therapeutics, a leading cell and gene therapy statrtup backed by entrepreneur Kiran Mazumdar-Shaw, has unveiled Qartemi, the ...